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Summary: The observation of suggestive clinical symptoms in a patient suffering from a Gougerot-Sjögren syn-
drome led to a search for a cryoglobulin. Unusual physico-chemical features of this cryoglobulin were discovered,
using standard electrophoresis, immunoelectrophoresis, immunofixation and electroimmunotransfer. The main unu-
sual finding was that the cryoprecipitate was made up of a biclonal IgMic associated to polyclonal IgG. Therefore,
we suggest that this new form of cryoglobulin be classified as a subtype lib, thus distinguishing two subtypes in
the usual classification.
Introduction
Cryoglobulins have been classified into three types ac-
cording to the characteristics of the constituting Ig (1):
type I corresponds to the presence of a single monoclo-
nal Ig; type II is formed of a monoclonal Ig and poly-
clonal Ig, frequently a monoclonal rheumatoid IgM
complexed with polyclonal IgG; type III, in which only
polyclonal Ig are found, in low concentrations. The first
two types are mostly encountered in Waldenström mac-
roglobulinaemia, myeloma, other lymphoproliferative
diseases and immune disorders such as the Gougerot-
Sjögren syndrome. The third type is mostly encountered
in auto-immune or infectious diseases (2). Certain cases
of type II and type III are considered by some authors
as the so-called "mixed essential cryoglobulins", many
of which are now associated with hepatitis C virus infec-
tion and mostly contain IgG (either monoclonal, bi- or
multiclonal). They have been largely described and re-
viewed in recent years (3, 4). In contrast, biclonal IgM
evolving towards monoclonal IgM, associated to a pri-
mary Gougerot-Sjögren syndrome has not been yet de-
scribed, to our knowledge.
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2) SSA, SSB: an antigen A, B characterized by sera of certain
patients with Sjögren syndrome (SS)
Sm: antigen (nuclear glycoprotein) called according to the initials
of the patient where it occurred
RNP: ribonucleoprotein
Scl70: an antigen of Mr = 70 000 identified by sera of certain
patients with sclerodermia (Scl) Jo-1: an antigen which is found in
polymyositis and dermatomyositis.
Reference: Lakomek et al.; this J. 1983, 21:621-32.
Materials and Methods
Case history
A 65-year-old woman with primary Sjören syndrome known for
10 years, and assessed by labial salivary glands biopsy, was admit-
ted at the hospital at the end of December 1994 because of a white,
soft and painless lower limb oedema, pitting and rising up to the
lumbar region. Clinical examination showed a blood pressure at
21.3/12.0 kPa, a 7 kg weight increase (present weight is 52.5 kg).
Raynaud's phenomenon, xerostomia and a definite xerophthalmia
were present. Further clinical examination was non-contributive.
Biological features revealed an incomplete nephrotic syndrome,
with proteinuria (4.45 g/24 h), hypoprotidaemia (43 g/1) and hypo-
albuminaemia (20.8 g/1). Urinary cytobacteriological tests showed
a microscopic haematuria; electrophoresis of urinary proteins
showed a predominance of albumin (77.8%). Renal function was
normal. -Glutamyltransferase was increased to 5 times the refer-
ence value.
A mixed, type II cryoglobulinaemia was present, the composition
of which will be detailed below.
Immunological tests yielded the following results: presence of anti-
nuclear antibodies at the 1/200 dilution, with an Ml speckled as-
pect (by indirect immunofluorescence technique on Hep. 2 cells),
and an SSA specificity (55 Units); other antibodies against soluble
nuclear antigen, e. g. SSB, Sm, RNP, Scl 70 and Jo-12) were absent.
Anti-mitochondria antibodies were present at 1/100, with an M2
aspect. Hepatitis B surface (HBs) antigen was not detected, serolo-
gic tests for hepatitis C were negative. Hepatitis C virus was absent,
as shown by polymerase chain reaction. Complete haematological
investigations including osteomedullary biopsy did not reveal any
sign of tumoural development.
Renal biopsy showed a cryoglobulin related damage. There were
neither extra-capillary crescents, nor tubulo-interstitial conse-
quences. Anti-IgG and anti-IgM antisera revealed granular, mostly
parietal positive staining corresponding to the cryoglobulin type.
Corticosteroid therapy (1 mg/kg · d, or 50 mg/d) was started, asso-
ciated to saluretic furosemide (Lasilix®, 60 mg/d) and anti-hyper-
tensive nicardifine (Loxen 50®, 3 tablets, 150 mg per day).
Evolution was favourable with regression of oedema, weight loss
of 10kg. After a 2 month corticosteroid therapy, proteinuria
dropped to 1.5 g/24 h, total serum protein raised to 60 g/1, as well
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as serum albumin (34 g/1). Cryoglobulin was still present. Cortico-
steroid therapy was then progessively reduced until a total span
of 5 months. At the end of this treatment, proteinuria was almost
physiological (0.15 g/24 h) and cryoglobulin had disappeared.
Four months after stopping corticosteroid therapy, a recurrence of
the nephrotic syndrome was observed, with proteinuria (1.75g/
24 h) and hypoalbuminaemia (28 g/1). Cryoglobulin reappeared,
with an apparently different content, which was analyzed as de-
scribed below. Haematological tests still revealed no sign of lym-
phoma.
Corticosteroid therapy (50 mg/d) was reintroduced allowing a drop
of the proteinuria to 0.70 g/24 h, after 3 months. An alternate corti-
costeroid therapy was then started for 2 years: 50 mg/kg · d, one
every other day. At the present time, cryoglobulin is persistent, but
nephrotic syndrome has not reappeared.
Sera
Two specimens were collected, on 23 December 1994 and 15 Sep-
tember 1995 (at the time of nephrotic syndrome recurrence).
Blood was drawn in a dry sampling vial and kept at 37 °C until
complete clotting. Then serum was separated, still at 37 °C.
Screening for monoclonal immunoglobulins
Cellulose acetate electrophoresis was performed with whole sera
at 37 °C in order to look for monoclonal immunoglobulins. All
material used were from Sebia (92130 Issy-les-Moulineaux,
France).
Cryoglobulin detection
After adding sodium azide (100 mg/1), sera were stored at 4 °C for
24 hours, then visually examined for cryoprecipitate.
Study of cryoprecipitates
The cryoprecipitates were isolated and washed three times with
NaCl 150 mmol/1 at 4 °C according to the classical technique (1).
They were strictly maintained at a temperature between 37 and
40 °C until analysis. Purity of cryoprecipitates was checked by im-
munoelectrophoresis, using an antiserum against human serum to-
tal proteins (5).
Typing of the cryoglobulins was performed by immunoelectropho-
resis (6), immunofixation (7) and electroimmunotransfer (8).
The serum sampled on 23 December 1994 yielded a cryoprecipi-
tate, termed A; serum sampled on 15 September 1995 yielded cryo-
precipitate B.
Results and Discussion
The known Gougerot-Sj gren syndrome of this patient
has been complicated with a cryoglobulinaemia after a
10 year evolution, as described in frequent cases (2),
20% to 40% of the cases according to some authors (12,
14). This cryoglobulinaemia has been responsible for
membrano-proliferative glomerulonephritis, as the ori-
gin of the nephrotic syndrome.
The aetiologic investigations of this Gougerot-Sj gren
syndrome associated to a type II cryoglobulinaemia in-
cluded the search for a lymphoproliferative syndrome:
clinical examination found no peripheral lymphadenopa-
thy, nor did thoraco-abdominal computer tomography
scan find any profound adenopathy. Bone marrow aspi-
rate and biopsy evidenced no malignant tumoural in-
filtrate. Collagen disease could not be evidenced; a viral
C infection could have been at the origin of the cryoglo-
bulinaemia, but hepatitis C serology and hepatitis C
virus PCR tests were negative.
The hypothesis of a primary biliary cirrhosis has been
raised in light of both the increase of γ-glutamyltransfer-
ase to 5 times the reference value and the presence of
type M2 anti-mitochondria antibodies.
A hepatic biopsy was done but the normal aspect of the
biliary ducts did not lead to this diagnostic.
As for therapy, a favourable evolution has been induced
by corticoids, but its initial 5 months duration proved to
be insufficient, with recurrence of nephrotic syndrome
and cryoglobulinaemia 4 months after. A lengthened
corticosteroid therapy for at least one year was then
started again.
Although no monoclonal immunoglobulin was detected
by electrophoresis, an abundant cryoprecipitate was
found in both sera after 24 h at 4 °C. The precipitation
temperature was determined to be between 37 and 30 °C
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Fig. 1 Immunoelectrophoresis and immunofixation analysis of
cryoprecipitate A (isolated from specimen drawn on 23/12/1994).
Names of sera are in standard characters, names of antisera are
in italics.
A: cryoprecipitate A
A(r): cryoprecipitate A reduced with cysteine hydrochloride
"NHS": normal human serum was used as control
Whole serum: matching whole serum
Total protein: anti-total protein antiserum
IgG: anti-IgG antiserum
IgM: anti-IgM antiserum
λ: anti-λ light chains (bound and free) antiserum
κ: anti-K light chains (bound and free) antiserum
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in both cases, which is not very common (9). This case
confirms that temperature is more important than quan-
tity, as underlined by the same authors (9), because it
explains typical clinical features despite the low concen-
tration of this cryoglobulin. Immunoelectrophoresis (fig.
1, anti-human serum total protein antiserum) demon-
strated the absence of albumin, thus proving the purity
of the cryoprecipitate. Anti-IgG, anti-IgM, anti-κ light
chains (bound and free) and anti-λ light chains (bound
and free) revealed the presence of a monoclonal IgMic
and of polyclonal IgG. This located the cryoglobulin in
type II of the current classification (1).
Immunoelectrophoresis of cryoprecipitate A exhibited a
more abundant non-specific precipitate at the well cath-
odic edge than did that of the second precipitate. Conse-
quently, immunofixation was performed to further ex-
plore these aspects.
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Fig. 2 Immunoelectrophoresis and immunofixation analysis of
cryoprecipitate B (isolated from specimen drawn on 15/09/1995).
Same legend as for figure 1, with:
B: cryoprecipitate B
B(r): cryoprecipitate B reduced with cystein hydrochloride
Figure 2 shows that cryoprecipitate A contained two dis-
tinct bands reacting with anti-μ and anti-κ antisera,
while cryoprecipitate B contained only one.
Electroimmunotransfer (8) was then performed to ex-
clude the improbable presence of IgM monomers. As a
matter of fact, IgM monomers are considered to lack
the capacity to cryoprecipitate (10, 11). The results of
electroimmunotransfer applied to cryoprecipitate A evi-
denced (fig. 3) that this cryoglobulin did not contain
A(r)
l^^^^r
Fig. 3 Electroimmunotransfer of cryoprecipitate A (left), with
control (right). Same legend as for figure 1.
-· shows absence of monomers in cryoprecipitate A.
—» shows control of electrophoresis -A(r)- and transfer -IgM, κ- of
reduced cryoprecipitate.
IgM monomers. Therefore, we were led to conclude that
both monoclonal IgM were polymers.
Cryoprecipitate A is composed of two monoclonal com-
mon polymeric IgMK, or biclonal IgM (according to
usual techniques), and polyclonal IgG, an observation
that has never been described before to our knowledge.
The closest resembling case was cited by Musset et al.
and corresponded in fact to a pentaclonal Ig (l IgG
+ 4 IgM), which was detectable in the corresponding
whole serum. Thus, we propose subdividing type II of
the current cryoglobulin classification into:
— type Ha, which would include cryoglobulins formed
of one monoclonal Ig and polyclonal Ig (corresponding
to type II of the previous classification);
— type lib, which would be defined as cryoglobulins
made up of two (or more) monoclonal Ig (multiclonal
Ig) and polyclonal Ig. As suggested by previous authors
(3), and by a frequent observation done in current prac-
tice, a progressive spreading of the cases could be distin-
guished inside this subtype, from bi- to tri- to
multiclonal Ig, the latter could be the closest category to
type III, whatever the concentrations found.
In our present case, cryoglobulin isolated from the first
sample belongs to type lib, cryoglobulin from the se-
cond sample is of type Ila.
The evolution within 9 months of a biclonal component
of a cryoglobulin towards a monoclonal component
seems interesting. Although it has been suggested (12)
that oligoclonal lymphocyte expansion could precede a
malignant state, there are no significant works, to our
knowledge, stating that a change from circulating bi- or
triclonal Ig to monoclonal Ig is a meaningful prognostic
criterion. However, it has to be noted that, in our present
case, the reappearance of a monoclonal cryoglobulin is
correlative to the recurrence of the nephrotic syndrome,
while it was initially biclonal, and had disappeared with
corticosteroid therapy. The absence of any lymphoproli-
ferative syndrome proves that this evolution does not
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correspond to a malignant dysglobulinaemia. It would
rather make it classify as an "associated dysglobulinae-
mia", according to the authors' classification (5): "asso-
ciated dysglobulinaemia" include all cases which are as-
sociated to an immunological disorder. This is consistent
with the statement according to which lymphoma is a
rare complication of primary Sjögren's syndrome (13).
As for the theoretical aspects of the cryoprecipitation
phenomenon, our observation would tend to prove that
in this case, the different Ig are not bound together. As
a matter of fact, our results clearly show (even more
evidently than in usual cases of type II cryoglobulins)
that the two monoclonal IgM and the polyclonal IgG
migrate independently: the different length and curve of
the two IgG and IgM arcs imply two distinct fractions;
the obvious difference in aspect and migration position
of the immunofixation bands also suggest non-com-
plexed types of molecules. Thus, they do not seem to be
bound in any manner. Otherwise, we would get a similar
aspect of the IgM and the IgG fractions, probably as a
mixture or indefinite aspect in terms of arc length and
curve in immunoelectrophoresis, and in the narrowness
or broadness of the immunofixation bands.
So, as a recent work tends to show (14), we think that
the Ig components of mixed (type II) cryoglobulins co-
precipitate independently, without any bonding. Thus,
the reason for the cryoprecipitation phenomenon must
be searched for in the structure of each molecule im-
plied. The rather significant volume of the cryoprecipi-
tate compared to the extremely low concentration of Ig
(undetectable by electrophoresis) would suggest the
presence of a non-protein substance. The type of binding
involved in the cryoprecipitate, either of the antigen-
antibody type or resulting from another mechanism
could not be explored on these specimens.
Conclusion
A new evolutive aspect of a cryoglobulinaemia is de-
scribed in a patient with Gougerot-Sjögren syndrome.
The serum drawn at first exhibits a peculiar type II cryo-
globulin, made of a biclonal IgMK and of polyclonal
IgG. Nine months later, the biclonal IgMK has evolved
to a monoclonal IgMK, raising the question of the prog-
nostic meaning of such observations.
It is suggested that the classification of cryoglobulins be
modified, dividing type II into type Ha for monoclonal
Ig and type lib for bi or multiclonal Ig.
This work also shows that cryoprecipitation is not neces-
sarily an antigen-antibody phenomenon and that its
mechanism more probably proceeds from a structural
basis of some Ig.
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